Download PDF
Aktuelle Ernährungsmedizin 2002; 27(1): 43-46
DOI: 10.1055/s-2002-20010
Originalbeitrag
© Georg Thieme Verlag Stuttgart · New York

Klinische Aspekte der Hyperkaliämie

Clinical Aspects of HyperkalaemiaT.  Franz1 , P.  Gross1
  • 1Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus Dresden
Manuskript nach einem Vortrag bei der 15. Irseer Fortbildungsveranstaltung der DGEM, 27. 10. 2001
Further Information

Publication History

Publication Date:
11 February 2002 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Hyperkaliämie ist eine häufige und weiter zunehmende Erkrankung. Die Genese ist meist durch das Zusammentreffen mehrerer Faktoren bedingt. Diese sind nicht selten iatrogen verursacht. Zunehmendes Alter des Patienten, Diabetes mellitus, Störungen des Renin-Angiotensin-Aldosteron-Systems, antibiotische Hochdosistherapie und Immunsuppressiva sind Ursachen der Hyperkaliämie. Pathophysiologisch stehen vier Mechanismen im Vordergrund: Nierenfunktionsstörung, hyporeninämischer Hypoaldosteronismus, tubuläre Störungen, zelluläre Störungen.

Abstract

Hyperkalaemia is a frequent disorder. Usually the combined action of several causative factors is required to bring about a hyperkalaemia. They are often iatrogenic. Increasing age, diabetes mellitus, disorders of the renin-angiotensin-aldosterone system, high-dose antibiotics and immunosuppressive treatment may result in hyperkalaemia. The most important pathogenetic mechanisms are renal insufficiency, hypoaldosteronism, tubular disorders and cellular disorders.

Literatur

  • 1 Paice B, Gray J MB, McBride D, Donnelly T, Lawson D H. Hyperkalemia in patients in hospital.  BMJ. 1983;  285 1189-1192
    PubMedSearch in Google Scholar
  • 2 Moore M L, Bailey R R. Hyperkalemia in patients in hospital.  N Z Med J. 1989;  102 557-558
    PubMedSearch in Google Scholar
  • 3 Shemer J, Modan M, Ezra D, Cabili S. Incidence of hyperkalemia in hospitalized patients.  Isr J Med Sci. 1983;  19 659-661
    PubMedSearch in Google Scholar
  • 4 Dreifus L S, Pick A. A clinical correlative study of the electrocardiogram in electrolyte imbalance.  Circulation. 1956;  14 815-825
    PubMedSearch in Google Scholar
  • 5 Hrnciar J. Diabetic nephropathie and isolated hyporenin hypoaldosteronism.  VNITR LEK. 1996;  42 (6) 394-399
    PubMedSearch in Google Scholar
  • 6 The CONSENSUS Trial Study Group . Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study.  N Engl J Med. 1987;  316 1429-1436
    CrossrefPubMedSearch in Google Scholar
  • 7 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients.  N Engl J Med. 2000;  342 145-153
    CrossrefPubMedSearch in Google Scholar
  • 8 Pitt B, Zannad F, Remme W J, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.  N Engl J Med. 1999;  341 709-717
    Search in Google Scholar
  • 9 Lewis E J, Hunsicker L G, Bain R P, Rohde R D. The Collaborative Study Group . The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy.  N Engl J Med. 1993;  329 1456-1462
    CrossrefPubMedSearch in Google Scholar
  • 10 Effectiveness of spironolacton added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure. Am J Cardiol 1996 78 (8): 902-907
    Search in Google Scholar
  • 11 Wen S F. Nephrotoxicities of nonsteroidal anti-inflammatory drugs.  J Formos Med Assoc. 1997;  96 (3) 157-171
    PubMedSearch in Google Scholar
  • 12 Oster J R, Singer I, Fishman L M. Heparin-induced aldosterone suppression and hyperkalemia.  Am J Med. 1995;  98 (6) 575-586
    CrossrefPubMedSearch in Google Scholar
  • 13 Schepkens H, Vanholder R, Billiouw J M, Lamaire N. Life-threatening Hyperkalemia during Combined Therapy with Angiotensin-converting Enzyme Inhibitors and Spironolactone: An Analysis of 25 Cases.  Am J Med. 2001;  110 438-441
    CrossrefPubMedSearch in Google Scholar
  • 14 Singhvi S M, Duchin K L, Morrison R A, Willard D A, Everett D W, Frantz M. Disposition of fosinopril sodium in healthy subjects.  Br J Clin Pharmacol. 1988;  25 9-15
    PubMedSearch in Google Scholar
  • 15 Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, O'Grady P, Yee K F, Liao W C, Mangold B. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestivee heart failure and chronic renal insufficiency.  Br J Clin Pharmacol. 2000;  49 23-31
    CrossrefPubMedSearch in Google Scholar
  • 16 Mousa D, Rassoul Z, Popovich W, Hassan A, Margate V, Hawas F, Suleiman M, Khader A A. A New Treatment for Interdialytic Hyperkalemia - The Use of Fosinopril Sodium.  Am J Nephrol. 1999;  19 395-399
    CrossrefPubMedSearch in Google Scholar
  • 17 Don B R, Schambelan M. Hyperkalemia in acute glomeulonephritis due to transient hyporeninemic hypoaldosteronism.  Kidney Inst. 1990;  38 (6) 1159-1163
    PubMedSearch in Google Scholar
  • 18 Deppe C E, Heering P J, Tinel H, Kinne-Saffran E, Grabensee B, Kinne R K. Effect of cyclosporin A on Na+/K+-ATPase in MDCK cells and two subtypes, C7 and C11.  Exp Nephrol. 1997;  5 (6) 471-480
    PubMedSearch in Google Scholar
  • 19 Kamel K S, Ethier J, Quaggin S, Levin A, Albert S, Carlisle E J, Halperin M L. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporin.  J Am Soc Nephrol. 1992;  2 (8) 1279-1284
    PubMedSearch in Google Scholar
  • 20 Perazella M A. Hyperkalemia in the elderly. A group at high risk.  Conn Med. 1996;  60 (4) 195-198
    PubMedSearch in Google Scholar
  • 21 Noto H, Kaneko Y, Takano T, Kurokawa K. Severe hyponatriemia and hyperkalemia induced by trimethoprom-sulfamethoxazol in patients with Pneumocystis carinii pneumonia.  Intern Med. 1995;  34 (2) 96-99
    PubMedSearch in Google Scholar
  • 22 Briceland L L, Bailie G R. Pentamidine-associated nephrotoxicity and hyperkalemia in patients with AIDS.  DAPHE. 1991;  25 (11) 1171-1174
    PubMedSearch in Google Scholar
  • 23 Clausen T. Adrenergic control of Na/K-homeostase.  Acta Med Scand Suppl. 1983;  672 111-115
    PubMedSearch in Google Scholar
  • 24 Smith T W. Digitalis. Mechanism of action and clinical use.  N Engl J Med. 1988;  318 358-365
    PubMedSearch in Google Scholar
  • 25 Salem M M, Rosa R M, Batlle D C. Extrarenal potassium tolerance in chronic renal failure. Implications of the treatment of acute hyperkalemia.  Am J Kidney Dis. 1991;  18 (4) 421-440
    PubMedSearch in Google Scholar
  • 26 Mimura M, Makino H, Knatsuka A, Yoshida S. Reduction of erythrocyte (Na+-K+)ATPase activities in non-insulin-depent diabetic patients with hyperkalemia.  Metab Clin Exp. 1992;  41 (4) 426-430
    PubMedSearch in Google Scholar
  • 27 Hughes M, Grant I S, Biccard B, Nimmo G. Suxamethonium and Critical Illness Polyneuropathy.  Anaesth Intensive Care. 1999;  27 636-638
    PubMedSearch in Google Scholar
  • 28 Mandelberg A, Krupnik Z, Houri S, Smetana S, Gilad E, Matas Z, Priel I E. Salbutamol Metered-Dose Inhaler With Spacer for Hyperkalemia.  Chest. 1999;  115 617-622
    CrossrefPubMedSearch in Google Scholar
  • 29 Blumberg A, Weidmann P, Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.  Kidney Int. 1992;  41 369-374
    PubMedSearch in Google Scholar
  • 30 Gerstmann B B, Kirkman R, Platt R. Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol.  Am J Kidney Dis. 1992;  20 159-161
    PubMedSearch in Google Scholar
  • 31 DeFronzo R A, Felig P, Ferrannini E, Wahren J. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man.  Am J Physiol. 1980;  238 E421-E427
    PubMedSearch in Google Scholar
  • 32 Gruy-Kapral C, Emmett M, Santa Ana C A, Porter J I, Fordtran J S, Fine K. Effect of single dose resin-carthartic therapy on serum potassium concentration in patients with end-stage renal disease.  J Am Soc Nephrol. 1998;  10 1924-1930
    PubMedSearch in Google Scholar
  • 33 Gordon R D. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate.  Hypertension. 1986;  8 (2) 93-102
    PubMedSearch in Google Scholar

Dr. Thorsten Franz
Prof. Dr. Peter Gross

Universitätsklinikum Carl Gustav Carus Dresden · Medizinische Klinik III

Fetscherstraße 74

01307 Dresden